Health & Fitness
Fri, November 18, 2011
CHAPEL HILL, N.C.--([ BUSINESS WIRE ])--POZEN Inc. (NASDAQ: POZN), a pharmaceutical company committed to transforming medicine that transforms lives, announced today that John R. Plachetka, Pharm.D., the Companyas Chairman, President and Chief Executive Officer, will present at the Piper Jaffray 23rd Annual Healthcare Conference on Wednesday, November 30, 2011 at 2:30 p.m. (ET), at The New York Palace Hotel. Dr. Plachetkaas presentation will be webcast and available for replay on POZENas home page at [ www.pozen.com ].
About POZEN
POZEN Inc. is a progressive pharmaceutical company that is transforming how the healthcare industry addresses unmet medical needs. By utilizing a unique in-source model and focusing on integrated therapies, POZEN has successfully developed and obtained FDA approval of two self-invented products in two years a" something almost no other small pharmaceutical company has done. Funded by these two milestone/royalty streams, POZEN is now creating a portfolio of cost-effective, evidence-based integrated aspirin therapies designed to enable the full power of aspirin by reducing its GI damage.
The Companyas common stock is traded on The NASDAQ Global Market under the symbol aPOZNa. For more detailed company information, including copies of this and other press releases, please visit [ www.pozen.com ].
